Top news

View all

Protecting more children, against more diseases, faster than ever before: Gavi, the Vaccine Alliance unveils plans for next 5-year period

Gavi’s new Investment Opportunity outlines plans for the Vaccine Alliance to protect 500 million children, saving over 8 million lives between 2026 and 2030.

Gavi to boost access to life-saving human rabies vaccines in over 50 countries

Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exposure prophylaxis (PEP) as part of routine immunisation.

Gavi announces launch of preventive Ebola, routine multivalent meningitis, human rabies, and hepatitis B birth dose vaccination programmes

Gavi, the Vaccine Alliance today announced that the lower-income countries it supports can now apply to introduce four additional vaccines: preventive Ebola, human rabies vaccine for post-exposure prophylaxis, multivalent meningococcal…

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Visit page

Top VaccinesWork stories

View all stories

Five years to save 8 million lives: everything you need to know about Gavi’s Investment Opportunity

To achieve its goals, Gavi must raise at least US$ 9 billion for its next strategic cycle.

Fighting TB and stigma in the slums of Lagos

Zainab Danjaki, a community health frontliner who specialises in turberculosis, tells Chioma Umeha her story.

How day zero financing could help protect the world during the next pandemic

Gavi’s First Response Fund aims to secure immediate access to vaccines and to protect routine immunisation programmes during major public health emergencies.

Vaccines support

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Gavi supports vaccines against 20 infectious diseases, including COVID-19, Ebola, malaria and rabies. Learn more about our support for each vaccine by clicking below.

Visit page

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Visit page

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter